Back to results
US 2024/0390388 A1Published application
Tricyclic compounds and use thereof
AssigneeMedshine Discovery Inc.
InventorsJingjie HUANG, Tao YU, Ye TAN, Chengde WU, Shuhui CHEN
Life of this patent
Estimating the term…
Abstract
A series of tricyclic compounds and the use thereof. Specifically disclosed are a compound as represented by formula (II) and a pharmaceutically acceptable salt thereof.
Claims20
A compound of formula (II) or a pharmaceutically acceptable salt thereof,
- wherein
- T is selected from O and S;
- R1 is selected from —C1-3 alkyl- and —C1-3 alkyl-cyclopropyl-;
- R1 is selected from H and C1-3 alkyl, and the C1-3 alkyl is optionally substituted by 1, 2, or 3 Ra;
- R2 is selected from H, F, Cl, Br, I, OH, and C1-3 alkyl, and the C1-3 alkyl is optionally substituted by 1, 2, or 3 Rb;
- X and Y are each independently selected from O and NR3, and X and Y are not selected from O at the same time;
- R3 is independently selected from H, OH, CN, C1-3 alkyl, C1-3 alkoxy, and —O-C3-5 cycloalkyl, and the C1-3 alkyl, C1-3 alkoxy, and —O-C3.5 cycloalkyl are optionally substituted by 1, 2, or 3 Rc;
- R4 and R5 are selected from H, F, Cl, Br, I, OH, and C1-3 alkyl;
- R6 is selected from H and C1-3 alkyl;
- R7 is selected from C1-3 alkyl, C1-3 alkoxy, and 3- to 5-membered heterocycloalkyl;
- or, R6, R7 together with the carbon atom they share form a 3- to 5-membered heterocycloalkyl;
- or, R1, R7 together with the atom to which they are attached form a 3- to 5-membered heterocycloalkyl;
- ring B is selected from 4- to 8-membered heterocycloalkyl, and the 4- to 8-membered heterocycloalkyl is optionally substituted by 1, 2, or 3 Rd;
- Ra, Rb, Rc, and Rd are each independently selected from F, Cl, Br, and I.
11 more elements
A compound of the following formula or a pharmaceutically acceptable salt thereof, selected from
Dependencies are inferred from the claim text.